The mRNA Revolution When the COVID-19 pandemic struck, the world's medical community initially prepared for a disaster of the scale of the Spanish Flu, which struck during WW1 and killed 50 million ...
RNA molecules are short-lived and fragile, constantly under threat from enzymes that degrade them. Unlike the more stable ...
TuHURA Biosciences announces completion of merger transaction with Kintara Therapeutics: Tampa, Florida Saturday, October 19, 2024, 15:00 Hrs [IST] TuHURA Biosciences, a phase 3 r ...
Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...
Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...
Combined company will operate as TuHURA Biosciences, Inc. and advance pipeline of novel technologies to overcome resistance to cancer immunotherapy ...